Vanguard Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712M | Buy |
|
|||||
|
2025
Q1 | $515M | Sell |
|
|||||
|
2024
Q4 | $414M | Buy |
|
|||||
|
2024
Q3 | $362M | Buy |
|
|||||
|
2024
Q2 | $356M | Buy |
|
|||||
|
2024
Q1 | $409M | Buy |
|
|||||
|
2023
Q4 | $517M | Buy |
|
|||||
|
2023
Q3 | $297M | Sell |
|
|||||
|
2023
Q2 | $201M | Sell |
|
|||||
|
2023
Q1 | $200M | Buy |
|
|||||
|
2022
Q4 | $80.7M | Buy |
|
|||||
|
2022
Q3 | $99.4M | Buy |
|
|||||
|
2022
Q2 | $89.9M | Buy |
|
|||||
|
2022
Q1 | $95.7M | Buy |
|
|||||
|
2021
Q4 | $156M | Sell |
|
|||||
|
2021
Q3 | $442M | Sell |
|
|||||
|
2021
Q2 | $691M | Buy |
|
|||||
|
2021
Q1 | $575M | Buy |
|
|||||
|
2020
Q4 | $458M | Buy |
|
|||||
|
2020
Q3 | $236M | Buy |
|
|||||
|
2020
Q2 | $189M | Buy |
|
|||||
|
2020
Q1 | $68.7M | Buy |
|
|||||
|
2019
Q4 | $75M | Buy |
|
|||||
|
2019
Q3 | $34.2M | Buy |
|
|||||
|
2019
Q2 | $2.35M | Buy |
|